Cipla 031 150 mg Pill: red, capsule/oblong
The pill with imprint Cipla 031 150 mg (Red, Capsule/Oblong, 0mm) has been identified as Nilotinib 150 mg and is used for Chronic Myelogenous Leukemia. It belongs to the drug class BCR-ABL tyrosine kinase inhibitors and is not a controlled substance.
Images for Cipla 031 150 mg
Nilotinib
- Imprint
- Cipla 031 150 mg
- Strength
- 150 mg
- Color
- Red (red opaque cap and red opaque body)
- Shape
- Capsule/Oblong (hard gelatin capsule)
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA, Inc.
- Manufacturer
- Genvion Corporation
- National Drug Code (NDC)
- 69097-0031
See also:
More about nilotinib
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (40)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.